Literature for BN 82204 (prodrug C01.032, C02.002 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2006
1. Burdi,R., Didonna,M.P., Pignol,B., Nico,B., Mangieri,D., Rolland,J.F., Camerino,C., Zallone,A., Ferro,P., Andreetta,F., Confalonieri,P. and De Luca,A.
   First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant
   Neuromuscul Disord (2006) 16, 237-248. PubMed  Europe PubMed DOI  I
2. [YEAR:2-2-2006]Fareed,M.U., Evenson,A.R., Wei,W., Menconi,M., Poylin,V., Petkova,V., Pignol,B. and Hasselgren,P.O.
   Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression
   Am J Physiol Regul Integr Comp Physiol (2-2-2006) 290, R1589-R1597. PubMed  Europe PubMed DOI  I
3. Pignol,B., Auvin,S., Carre,D., Marin,J.G. and Chabrier,P.E.
   Calpain inhibitors and antioxidants act synergistically to prevent cell necrosis: effects of the novel dual inhibitors (cysteine protease inhibitor and antioxidant) BN 82204 and its pro-drug BN 82270
   J Neurochem (2006) 98, 1217-1228. PubMed  Europe PubMed DOI  I